Loading...
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial
The aim of this study was to evaluate the clinical effects of dexamethasone administration in patients with mild to moderate acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19). The study included 50 patients who were randomly assigned to the dexamethasone group or...
Na minha lista:
| Udgivet i: | Eur J Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier B.V.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7885705/ https://ncbi.nlm.nih.gov/pubmed/33607104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2021.173947 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|